March 2019 FDA Recall Testosterone by Lupin Pharmaceuticals Inc.
D-1010-2019 - Defective Container

This Class III drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on March 13, 2019 for the product Testosterone. The FDA reported the reason for recall as defective container. The product was distributed in Recalled product was distributed to 7 major wholesale/drug chain distributors and 1 supermarket chain that may have further distribute the product throughout the United States. and the recall is currently terminated.

Recall Number: D-1010-2019

Reason for Recall
Defective Container: Repetitive complaints received indicating pump not working.
Initiated
03-13-2019
Reported
03-27-2019
Quantity
3,200 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Lupin Pharmaceuticals Inc.
Recalled product was distributed to 7 major wholesale/drug chain distributors and 1 supermarket chain that may have further distribute the product throughout the United States.
Testosterone Topical Solution, 30mg/1.5mL, 110mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-943-11

Batch or Lot Expiration Information

Lot# K700086, Exp 11/2019

Affected Packages Involved in this Recall